Article
Both estradiol and tamoxifen decrease proliferation and invasiveness of cancer cells transfected with a mutated estrogen receptor.
The Journal of steroid biochemistry and molecular biology - 1 Apr 1997
Garcia M, Derocq D, Platet N, Bonnet S, Brouillet J P, Touitou I, Rochefort H
Abstract excerpt
Previous studies have shown that, after wild-type estrogen receptor (ER) transfection in ER-negative breast cancer cells, estradiol but not tamoxifen prevents growth, invasiveness and metastasis of these cells in mice. Because an ER mutation at position 400 converts the triphenylethylene antiestrogen, OH-tamoxifen into a full estrogen agonist, we transfected this mutated form of human ER in an ER-negative rat...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
